What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline-Reference-Cited by-同舟云学术

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline

Published:2011-05 Issue:5 Volume:37 Page:415-419
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Livermore David M.,Warner Marina,Mushtaq Shazad,Doumith Michel,Zhang Jiancheng,Woodford Neil

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study;Kumarasamy;Lancet Infect Dis,2010

2. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece—a review of the current evidence;Vatopoulos;Euro Surveill,2008

3. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria;Nordmann;Lancet Infect Dis,2009

4. Spread of OXA-48-encoding plasmid in Turkey and beyond;Carrer;Antimicrob Agents Chemother,2010

5. Hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the United Kingdom;Thomas,2009

Cited by 289 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imidazole‐Oxadiazole Hybrid as Potential Antimicrobial Agents: Design, Synthesis, Drug–Likeness, Pharmacophore and Molecular Docking Study;ChemistrySelect;2024-08-22

2. Isolation and Characterization of Novel Lytic Bacteriophages Infecting Carbapenem-Resistant Pathogenic Diarrheagenic and Uropathogenic Escherichia Coli;Infection and Drug Resistance;2024-08

3. Using honey bee colonies to monitor phenotypic and genotypic resistance to colistin;Chemosphere;2024-08

4. Chloramphenicol activity against carbapenemase producing Enterobacterales;Journal of Global Antimicrobial Resistance;2024-06

5. Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model;HEALTH TECHNOL ASSES;2024